Hypopharyngeal Cancer
📧 Sign up to get email alerts when something new happens for Hypopharyngeal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: A Machine Learning-Based Risk Prediction Model for Head and Neck Cancerous Lesions
This clinical trial update describes a machine learning-based risk prediction model for head and neck cancerous lesions, with recruitment no…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin [Phase 1]
Phase 1 trial evaluating the addition of M3814 (peposertib), a DNA-PK inhibitor, to radiation therapy in patients with advanced head and nec…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Study Title: Oncological and Functional Results After Total Laryngectomy and Pharyngolaryngectomy
This clinical trial update reports oncological and functional outcomes after total laryngectomy and pharyngolaryngectomy for laryngeal and h…
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating celecoxib added to surgery and radiation for advanced head and neck cancer; the study was terminated with results p…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck [Phase 1]
Phase Ib trial of buparlisib (BKM120) with cisplatin and radiotherapy in high-risk locally advanced squamous cell carcinoma of the head and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: WEE1 Inhibitor with Cisplatin and Radiotherapy: a Trial in Head and Neck Cancer [Phase 1]
Phase 1 trial evaluating a WEE1 inhibitor in combination with cisplatin and radiotherapy for head and neck cancers has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-28Clinical Trial Update: Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin [Phase 2]
Phase 2 trial evaluating sodium thiosulfate to prevent cisplatin-induced ototoxicity in patients with head and neck squamous cell carcinoma …
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: A New Delineation Approach for Oral Cavity, Oropharynx, Larynx and Hypopharynx in IMRT for Head and Neck Cancer [NA]
A completed clinical trial update describes a new delineation approach for defining target volumes in IMRT for head and neck cancer, focusin…
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Efficacy and Safety of Toripalimab Combined With AP-induced Chemotherapy Followed in Non-metastatic IVB Hypopharyngeal Cancer [Phase 2]
Phase 2 trial update investigating toripalimab with AP-induced chemotherapy in non-metastatic stage IVB hypopharyngeal cancer.
-
CLINICAL_TRIALS trial_result · 2023-12-20Clinical Trial Update: Induction TPN Followed by Nivolumab With Radiation in Locoregionally Advanced Laryngeal and Hypopharyngeal Cancer [Phase 2]
Phase 2 trial evaluating induction total parenteral nutrition followed by nivolumab and radiation for locoregionally advanced laryngeal and …
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial evaluating induction chemotherapy and toripalimab followed by radiotherapy for unresectable laryngeal or hypopharynge…
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: Induction Chemotherapy and Toripalimab for Larynx Preservation in Resectable Laryngeal/Hypopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial evaluating induction chemotherapy with toripalimab for larynx preservation in resectable laryngeal/hypopharyngeal car…
-
CLINICAL_TRIALS trial_result · 2021-08-19Clinical Trial Update: Induction Chemotherapy Combined With Camrelizumab in Locoregionally Advanced Hypopharyngeal Cancer [Phase 2]
Phase 2 trial update evaluating induction chemotherapy combined with camrelizumab for locoregionally advanced hypopharyngeal cancer.
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: New Strategy of Improving Treatment Outcome and Larynx-preservation Rate in Locally Advanced Hypopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial update aiming to improve treatment outcomes and larynx-preservation rates in locally advanced hypopharyngeal carcinom…
-
CLINICAL_TRIALS trial_result · 2021-01-15Clinical Trial Update: Pembrolizumab in Combination With CRT for LA-SCCHN [Phase 1]
Phase 1 study evaluating pembrolizumab in combination with chemoradiotherapy for locally advanced head and neck squamous cell carcinoma has …
-
CLINICAL_TRIALS trial_result · 2020-11-10Clinical Trial Update: Toripalimab Plus TPF Chemotherapy and Radiotherapy for LA-HPSCC [Phase 2]
Phase 2 clinical trial evaluating toripalimab in combination with TPF chemotherapy and radiotherapy for locally advanced hypopharyngeal squa…
-
CLINICAL_TRIALS trial_result · 2020-08-06Clinical Trial Update: Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial [Phase 3]
Randomized Phase 3 trial investigating induction chemotherapy for locally advanced hypopharyngeal carcinoma.
-
CLINICAL_TRIALS trial_result · 2020-04-15Clinical Trial Update: IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC [Phase 3]
Phase 3 trial comparing IMRT plus cisplatin to conventional radiotherapy plus cisplatin in stage III-IV head and neck squamous cell carcinom…
-
CLINICAL_TRIALS trial_result · 2020-02-20Clinical Trial Update: Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. [Phase 1, Phase 2]
Phase 1b/Phase 2 clinical trial evaluating food-based modulation of biomarkers in tissues from individuals at high risk for oral cancer has …
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN) [Phase 2]
Phase 2 trial update on neoadjuvant chemotherapy for locally advanced squamous cell cancer of the head and neck (hypopharyngeal cancer).
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma [Phase 3]
A Phase 3 trial comparing induction chemotherapy with cisplatin and 5-FU with or without docetaxel in patients with T3-T4 laryngeal and hypo…
-
CLINICAL_TRIALS trial_result · 2018-07-09Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx [Phase 3]
A Phase 3 trial from the European Organisation for Research and Treatment of Cancer evaluating combination chemotherapy plus radiation thera…
-
CLINICAL_TRIALS trial_result · 2018-07-09Clinical Trial Update: Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated adding lapatinib to chemoradiation in patients with locally advanced laryngeal or hypopharyngeal cancer…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: A Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuximab [Phase 2]
Phase II trial of standard chemoradiation with add-on cetuximab in advanced head and neck cancers has completed, evaluating cetuximab in oro…
-
CLINICAL_TRIALS trial_result · 2017-10-31Clinical Trial Update: 3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx [EARLY_Phase 1]
Early-phase trial using PET imaging to evaluate response to cetuximab plus cisplatin and radiation in advanced cancers of the oropharynx, la…